Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression

Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression

<p>Diabetes mellitus (DM)-induced cardiac morbidities have been the leading cause of death among diabetic patients. Recently, sodium-glucose cotransporter-2 (SGLT-2) inhibitors including empagliflozin (EMPA), which have been approved for the treatment of DM, have gained attention for their car...

Full description

Saved in:
Bibliographic Details
Main Author: Nabeel Abdulrahman (725914) (author)
Other Authors: Meram Ibrahim (14151348) (author), Jensa Mariam Joseph (14151351) (author), Hanan Mahmoud Elkoubatry (14151354) (author), Al-Anood Al-Shamasi (14151357) (author), Menatallah Rayan (14151360) (author), Alain Pierre Gadeau (14151363) (author), Rashid Ahmed (3900679) (author), Hussein Eldassouki (14151366) (author), Anwarul Hasan (1332066) (author), Fatima Mraiche (715733) (author)
Published: 2022
Subjects:
Biochemistry and cell biology
Medical biochemistry and metabolomics
Cell Biology
Clinical Biochemistry
Molecular Biology
General Medicine
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items